Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recurrent herpes simplex labialis: selected therapeutic options.

G Wayne Raborn1, Michael G A Grace

  • 1Dentistry Pharmacy Centre, University of Alberta, Edmonton, Alberta, Canada. wraborn@ualberta.ca

Journal (Canadian Dental Association)
|September 5, 2003
PubMed
Summary

Recurrent herpes simplex labialis (HSL), caused by herpes simplex virus 1 (HSV1), requires effective management. Antiviral therapies offer reduced healing time and pain for frequent recurrences across various patient groups and application methods.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of ursodeoxycholic acid in primary, type IIa or IIb hypercholesterolemia: a multicenter, randomized, double-blind clinical trial.

Atherosclerosis·2008
Same author

Steroid injection for osteoarthritis of the hip: a randomized, double-blind, placebo-controlled trial.

Arthritis and rheumatism·2007
Same author

Transverse morphology of the sacroiliac joint: effect of angulation and implications for fluoroscopically guided sacroiliac joint injection.

Skeletal radiology·2006
Same author

Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial.

Gastrointestinal endoscopy·2005
Same author

Treatment modalities and medication recommended by health care professionals for treating recurrent herpes labialis.

Journal of the American Dental Association (1939)·2004
Same author

Understanding variation in revenue and expenses.

Healthcare financial management : journal of the Healthcare Financial Management Association·2003

Area of Science:

  • Virology
  • Dermatology
  • Pharmacology

Background:

  • Recurrent herpes simplex virus 1 (HSV1) infection, known as herpes simplex labialis (HSL), is a widespread issue.
  • Frequent HSL recurrences, especially in immunocompromised individuals or those with significant morbidity, necessitate improved management strategies.
  • Established antiviral drugs like acyclovir, penciclovir, famciclovir, and valacyclovir have been available for two decades.

Purpose of the Study:

  • To outline preferred antiviral treatment strategies for herpes simplex labialis (HSL) in adults and children.
  • To detail appropriate drug choices and administration methods (intravenous, oral, topical) for diverse clinical scenarios.
  • To guide practitioners in managing HSL, considering factors like recurrence frequency, associated conditions, and specific triggers.

Related Experiment Videos

Main Methods:

  • Review of existing antiviral compounds (acyclovir, penciclovir, famciclovir, valacyclovir) and their efficacy.
  • Categorization of HSL treatment based on patient status (normal immunity, altered immunity) and clinical presentation (prodrome, no prodrome).
  • Consideration of specific situations triggering recurrence, such as dental procedures, surgery, or dermatological treatments.

Main Results:

  • Antiviral medications can potentially decrease healing duration, lesion size, and pain associated with HSL.
  • Treatment approaches vary based on the clinical context, including the presence of prodromal symptoms and the need for prophylaxis.
  • Different modes of administration (IV, oral, topical) are recommended depending on the severity and specific circumstances of HSL.

Conclusions:

  • A structured approach to antiviral therapy is crucial for effectively managing recurrent herpes simplex labialis (HSL).
  • Tailoring treatment to individual patient needs and clinical scenarios optimizes outcomes for HSV1 infections.
  • This review provides a practical framework for healthcare providers to utilize antiviral therapies for HSL management.